Jovita Kanoujia

Jovita Kanoujia

Auto-generated profile, based on publicly available information

Jovita Kanoujia

Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), Gwalior, India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2016 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
JVJyoti Verma
Jyoti Verma
JKJovita Kanoujia
Jovita Kanoujia
PPPoonam Parashar
Poonam Parashar
CTChandra Bhusan Tripathi
Chandra Bhusan Tripathi
SSShubhini A Saraf
Shubhini A Saraf

1 December 2016 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
JKJovita Kanoujia
Jovita Kanoujia
MSMahendra Singh
Mahendra Singh
PSPooja Singh
Pooja Singh
SSShubhini A Saraf
Shubhini A Saraf

12 December 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
RSRasika Suryawanshi
Rasika Suryawanshi
JKJovita Kanoujia
Jovita Kanoujia
PPPoonam Parashar
Poonam Parashar
SSShubhini A Saraf
Shubhini A Saraf
Sericin is a unique proteinaceous biopolymer obtained from cocoons of Bombyx Mori. It has become very popular since it is bestowed with numerous health benefits. Sericin is composed of 18 types of amino acids, out of which 8 amino acids play a significant role in human metabolic pathways. Sericin is easily amenable to make into novel dosage forms and also has been conferred with numerous therapeutic activities such as wound healing, antihypertensive, neuro-protective, antitumor, anti-diabetic, anti-wrinkle, anti-ageing and antioxidant amongst various others. This review summarizes the current status of sericin, as a therapeutic moiety with a focus on active constituents as well as their proposed mechanism in the treatment of various chronic diseases. It also summarizes previous and current in-vitro, in-vivo, cell lines studies and clinical trials based pieces of evidence corroborating the therapeutic activities of sericin.

1 June 2017 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SSSanju Singh
Sanju Singh
PPPoonam Parashar
Poonam Parashar
JKJovita Kanoujia
Jovita Kanoujia
ISIndu Singh
Indu Singh
SSSudipta Saha
Sudipta Saha
SSShubhini A. Saraf
Shubhini A. Saraf

1 February 2017 in Journal of Liposome Research
Verified
Journal Article
Closed access
NSNeelu Singh
Neelu Singh
PPPoonam Parashar
Poonam Parashar
CTChandra Bhushan Tripathi
Chandra Bhushan Tripathi
JKJovita Kanoujia
Jovita Kanoujia
GKGaurav Kaithwas
Gaurav Kaithwas
SSShubhini A Saraf
Shubhini A Saraf
Context: Gout is a painful disorder which does not have an efficient delivery system for its treatment. Objective: Development and in vitro, in vivo evaluation of allopurinol-loaded nonionic surfactant-based niosomes was envisaged. Materials and methods: Niosomes were prepared with Span 20 and Tween 20 (1:1 molar ratio) using ether injection method. The formulations were screened for entrapment efficiency, particle size analysis, zeta potential, release kinetics, in vivo activity, and stability studies. Result: Stable, spherical vesicles of average particle size 304 nm with zeta-potential and entrapment efficiency of 22.2 mV and 79.44 ± 0.02%, respectively, were produced. In vitro release study revealed 82.16 ± 0.04% release of allopurinol within 24 h. The niosomal formulation was further evaluated for its antigout potential in monosodium urate (MSU) crystal induced gout animal model. The formulation demonstrated significant uric acid level reduction and enhanced antigout activity when compared with the pure allopurinol. Discussion: The better antigout activity displayed by niosomal formulation could be attributed to sustained release of drug, higher drug solubility within biological fluids, better membrane interaction, smaller size, and presence of cholesterol and surfactant. Conclusions: This study reveals that niosomes can be an efficient delivery system for the treatment of gout.

18 July 2016 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
PSPooja Singh
Pooja Singh
MSMahendra Singh
Mahendra Singh
JKJovita Kanoujia
Jovita Kanoujia
MAMalti Arya
Malti Arya
SSShailendra K. Saraf
Shailendra K. Saraf
SSShubhini A Saraf
Shubhini A Saraf